Negotiated reimbursement rates for D3352 across 41 states, sourced from CMS Transparency in Coverage data. 444 rate records.
D3352 refers to the interim medication phase of apexification or recalcification. This procedure is performed after the initial visit and involves placing a medicament to promote root development. Clinical indications include the need for ongoing treatment of a non-vital tooth with an open apex. Proper documentation should include details of the medication used and the patient's response. Reimbursement for D3352 can vary significantly by payor and state, with some insurance plans providing partial coverage. The average reimbursement for this procedure is about $129.
Reimbursement rates for D3352 vary significantly by state, payor, and provider network. The national average negotiated rate is $129. Data sourced from CMS Transparency in Coverage machine-readable files, updated monthly.
38+ more states available with Pro ↓